These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1555493)

  • 1. Models of hepatic drug elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Rev; 1992; 24(1):49-88. PubMed ID: 1555493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on the interpretation of tracer dispersion in the liver.
    Weiss M
    J Theor Biol; 1997 Jan; 184(1):1-6. PubMed ID: 9039395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    Ching MS; Morgan DJ; Smallwood RA
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1048-54. PubMed ID: 2778709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated approach to model hepatic drug clearance.
    Liu L; Pang KS
    Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological principles of imipramine pharmacokinetics].
    Szymura-Oleksiak J
    Folia Med Cracov; 1989; 30(3-4):103-21. PubMed ID: 2641936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interconnected-tubes model of hepatic elimination.
    Anissimov YG; Bracken AJ; Roberts MS
    J Theor Biol; 1997 Sep; 188(1):89-101. PubMed ID: 9299312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The series-compartment model for hepatic elimination.
    Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):27-31. PubMed ID: 2881755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics.
    Iwatsubo T; Hirota N; Ooie T; Suzuki H; Sugiyama Y
    Biopharm Drug Dispos; 1996 May; 17(4):273-310. PubMed ID: 8845471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interconnected-tubes model of hepatic elimination: steady-state considerations.
    Anissimov YG; Bracken AJ; Roberts MS
    J Theor Biol; 1999 Aug; 199(4):435-47. PubMed ID: 10441461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.
    Roberts MS; Donaldson JD; Jackett D
    J Pharmacokinet Biopharm; 1989 Dec; 17(6):687-719. PubMed ID: 2635740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate.
    Nagata O; Murata M; Kato H; Terasaki T; Sato H; Tsuji A
    Drug Metab Dispos; 1990; 18(6):902-10. PubMed ID: 1981535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a biological tissue model based on a single-cell model: a computer simulation of metabolic heterogeneity in the liver lobule.
    Ohno H; Naito Y; Nakajima H; Tomita M
    Artif Life; 2008; 14(1):3-28. PubMed ID: 18171128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.